Original Article

Secondary non-Hodgkin lymphoma of the ethmoid sinus after temozolomide

Volume 11 · Issue 1 Publish Date: March 15, 2015
Full Text PDF
K. Broes
Department of Otorhinolaryngology, Head and Neck Surgery
L. Van Ginderachter
Department of Medical Oncology
E. Joosens
Department of Medical Oncology
A. Maes
Department of Radiation Oncology
K. Theunissen
Department of Hematology
S. Schepers
Department of Oral and Maxillofacial Surgery, Ziekenhuis Oost-Limburg, Genk, Belgium
K. Deben
Department of Otorhinolaryngology and Head & Neck Surgery, Jessa Hospital Campus Virga Jesse, Hasselt, Belgium
J. Claes
Department of Otorhinolaryngology and Head and Neck Surgery, Antwerp University Hospital, Edegem, Belgium
J. Mebis
Department of Medical Oncology
T. Cox
Department of Otorhinolaryngology and Head & Neck Surgery, Jessa Hospital Campus Virga Jesse, Hasselt, Belgium
Broes, K., Ginderachter, L. V., Joosens, E., Maes, A., Theunissen, K., Schepers, S., … Cox, T. (2015). Secondary non-Hodgkin lymphoma of the ethmoid sinus after temozolomide. B-ENT, 11(1), 73–76. Retrieved from https://www.b-ent.be/index.php/pub/article/view/570
Full Text Full Text PDF

Abstract

Secondary non-Hodgkin lymphoma of the ethmoid sinus after temozolomide. The paranasal sinuses are rarely the site of malignancy, especially non-Hodgkin lymphoma. In such cases, the ethmoid sinus is the second most frequently involved paranasal sinus. Diagnosis of these malignancies is difficult because the early symptoms often mimic benign sinus pathology. Thus, most cases are diagnosed at an advanced stage, and their prognosis is poor. Here we describe the case of a 58-year-old man with a secondary high-grade B-cell non-Hodgkin lymphoma of the ethmoid sinus. This malignancy was diagnosed two years after the patient had received treatment with temozolomide for a glioblastoma multiforme. This case highlights that malignant tumours of the paranasal sinuses should always be included in the differential diagnosis of sinus disease. Additionally, patients treated with temozolomide should receive regular follow-up care including vigilant evaluation for secondary tumours, such as non-Hodgkin lymphoma.

Similar Articles

Article Info
Published In
Journal B-ENT
Volume / Issue Volume 11 · Issue 1
Pages 73-76
History
Published Online March 15, 2015
Affiliations
K. Broes
Department of Otorhinolaryngology, Head and Neck Surgery
L. Van Ginderachter
Department of Medical Oncology
E. Joosens
Department of Medical Oncology
A. Maes
Department of Radiation Oncology
K. Theunissen
Department of Hematology
S. Schepers
Department of Oral and Maxillofacial Surgery, Ziekenhuis Oost-Limburg, Genk, Belgium
K. Deben
Department of Otorhinolaryngology and Head & Neck Surgery, Jessa Hospital Campus Virga Jesse, Hasselt, Belgium
J. Claes
Department of Otorhinolaryngology and Head and Neck Surgery, Antwerp University Hospital, Edegem, Belgium
J. Mebis
Department of Medical Oncology
T. Cox
Department of Otorhinolaryngology and Head & Neck Surgery, Jessa Hospital Campus Virga Jesse, Hasselt, Belgium
Cite this Article
Broes, K., Ginderachter, L. V., Joosens, E., Maes, A., Theunissen, K., Schepers, S., … Cox, T. (2015). Secondary non-Hodgkin lymphoma of the ethmoid sinus after temozolomide. B-ENT, 11(1), 73–76. Retrieved from https://www.b-ent.be/index.php/pub/article/view/570
Outlines